Top Medical Device CROs
Pharma Tech Outlook
Home »Medical Device CROs » Top Medical Device CROs
NAMSA: Accelerating Medical Device Commercialization
line

Top 5 Medical Device CROs - 2023

line

Medical research is constantly evolving, with discoveries and advances emerging every day. Biological and pharmaceutical companies are experiencing a surge in workload due to the rapid pace of innovation, so CROs assist the companies with streamlining and systematizing the research process. Medical device CROs provide research services contractually to medical device industries. Technology advancements have provided CROs with opportunities to further improve and evolve their services, such as technology-enabled patient recruitment and management, decentralized and remote trials, wearable technology, and biosimulation.

Medical device contract research organizations are projected to generate $14.01 bn in revenue by 2030, representing an 8.8 percent CAGR from 2023 to 2030. The increased demand for advanced devices for screening and monitoring surgical procedures is expected to result from this market growth. The industry is driven by the benefits of time-saving, cost-efficiency, and expertise, which promotes the production of devices faster. Contract research organizations will have access to the latest technological resources, such as hardware, software, and internet-based applications, to ensure that the process is as efficient as possible while maintaining the highest level of quality.

This edition of the Pharma Tech Outlook brings forth the most significant developments in medical device CRO providing services to medical device manufacturers to assist them with clinical trial design, execution, and data analysis.

It features thought leadership articles from Ozgur Akbulut, Director - Global Divestments and Contract Manufacturing Lead at Takeda [NYSE:TAK] James Riddle, MCSE, CIP, CPIA, CRQM, Vice President, Research Services & Strategic Consulting at Advarra. Ozgur Akbulut discusses how pharma companies seek efficient operational excellence and continuous improvement. James Riddle talks about how immunotherapy and gene editing may cure previously incurable conditions. It also features an article from Stewart Campbell, VP & General Manager at West Pharmaceutical & Li Chen, VP & General Manager at West Pharmaceutical, who sheds light on the shifting trends in oncology drug development that pose a challenge for manufacturing companies.

In this edition of Pharma Tech Outlook, we also bring you the story of some of the medical device CROs companies that cater to delivering disruptive technologies and tasks related to developing and commercializing their products. One of them is NAMSA, one of the world’s leading MedTech Contract Research Organizations (CRO), offering global end-to-end development services.

In this edition featuring the medical device CROs 2023, we hope you find the right partner for your organization’s performance and needs.

    Top Medical Device CROs

    NAMSA
    Read full profile →
    Helping medical device Sponsors improve healthcare since 1967, NAMSA is the world’s leading MedTech Contract Research Organization (CRO) offering global end-to-end development services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients’ products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, NAMSA is the industry’s premier, trusted partner for successful development and commercialization outcomes. ... read full profile
    Avania
    Avania is a fully-integrated global Contract Research Organization (CRO) that offers a comprehensive range of services. With a focus on medical devices, novel technology, and combination products, Avania guides products through every stage, including feasibility, analytics, clinical trials, consulting, medical writing, quality management, regulatory affairs, reimbursement, and more.
    BioPharma Services
    BioPharma Services is a leading contract research organization (CRO) specializing in clinical research and bioanalytical services. With state-of-the-art facilities and a dedicated team, they offer comprehensive solutions for pharmaceutical and biotechnology companies, ensuring efficient drug development and regulatory compliance.
    ProTrials Research
    ProTrials Research is a clinical research organization (CRO) that focuses on providing cutting-edge, effective, and regulatory-compliant solutions to the pharmaceutical, biotechnology, and medical device sectors. Leveraging their proficiency in project management, site selection, and data management, ProTrials guarantees seamless and prosperous execution of clinical trials.
    Qserve
    Qserve is dedicated to enhancing patient safety and well-being by facilitating the progress of biomedical technology. They provide comprehensive support to global manufacturers of medical devices and in-vitro diagnostics, aiding them in market access, medical device approvals, clinical trials, and the attainment and sustenance of regulatory compliance.